Hims & Hers Health (HIMS) Morgan Stanley Technology, Media & Telecom Conference summary
Event summary combining transcript, slides, and related documents.
Morgan Stanley Technology, Media & Telecom Conference summary
17 Dec, 2025Platform evolution and consumer experience
Focused on removing friction and stigma in healthcare by leveraging technology for awareness and accessibility.
Built a proprietary EMR system to connect patients and providers, enhancing convenience and personalization.
Over 55% of subscribers now use personalized products, up from less than 20% two years ago.
Transparent subscription pricing model covers medication, provider access, and follow-up care.
HSA support for weight management was introduced, with plans to expand value-added services.
Growth drivers and category expansion
Growth in core specialties like men's dermatology remains robust, with 55% year-over-year growth.
Learnings from established categories are applied to new ones, driving triple-digit growth in newer specialties.
Mental health and weight loss categories benefit from structured data and personalized treatment tools like MedMatch.
Weight loss offerings include oral medications and GLP-1s, with a $100M revenue run rate achieved in seven months.
Plans to introduce one to two new categories per year, focusing on chronic, top-of-mind conditions like low testosterone and menopausal support.
Technology, verticalization, and data
Vertical integration includes in-house EMR, affiliated pharmacies, and a new peptide facility to enhance control and speed of innovation.
AI and data are used to match users with effective treatments and provide proactive, personalized health insights.
At-home lab diagnostics will deepen personalization and reduce friction for users.
Platform investments aim to expand from hundreds to thousands of SKUs, increasing personalization and user engagement.
Latest events from Hims & Hers Health
- Personalized care, tech-driven growth, and global expansion fuel strong revenue and margin outlook.HIMS
Morgan Stanley Technology, Media & Telecom Conference 20262 Mar 2026 - 2025 revenue up 59% to $2.35B, with strong subscriber and specialty growth, and robust 2026 outlook.HIMS
Q4 202524 Feb 2026 - Q2 revenue up 52% to $315.6M, net income $13.3M, strong subscriber and margin growth.HIMS
Q2 20242 Feb 2026 - Personalized, tech-driven healthcare and GLP-1s fuel rapid growth and operational gains.HIMS
Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 20242 Feb 2026 - Directors were elected, auditor ratified, and executive pay approved; results to be filed.HIMS
AGM 20241 Feb 2026 - Q3 2024 revenue up 77% to $401.6M, net income $75.6M, and 2M subscribers.HIMS
Q3 202417 Jan 2026 - 2024 revenue up 69% to $1.5B, net income $126M, 2025 guidance set at $2.3–$2.4B revenue.HIMS
Q4 20247 Jan 2026 - Q1 revenue up 111% to $586M, with strong subscriber growth and raised full-year guidance.HIMS
Q1 202520 Dec 2025 - Shareholders to vote on board, auditor, and executive pay amid strong growth and governance.HIMS
Proxy Filing1 Dec 2025